Results 111 to 120 of about 21,948 (157)
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Nature Reviews Immunology, 2002
The B7-1/B7-2-CD28/CTLA-4 pathway is crucial in regulating T-cell activation and tolerance. New B7 and CD28 molecules have recently been discovered and new pathways have been delineated that seem to be important for regulating the responses of previously activated T cells.
Gordon J. Freeman, Arlene Sharpe
exaly +3 more sources
The B7-1/B7-2-CD28/CTLA-4 pathway is crucial in regulating T-cell activation and tolerance. New B7 and CD28 molecules have recently been discovered and new pathways have been delineated that seem to be important for regulating the responses of previously activated T cells.
Gordon J. Freeman, Arlene Sharpe
exaly +3 more sources
Current Opinion in Immunology, 1995
Until recently, it was thought that signal transduction through CD28 and the related molecule CTLA4 prevented the induction of anergy in T cells activated through the TCR. This hypothesis has been suggested as an explanation for how soluble forms of CTLA4, which bind the CD28/CTLA4 ligands B7-1 and B7-2, can prevent graft rejection.
L H, Boise, P J, Noel, C B, Thompson
openaire +2 more sources
Until recently, it was thought that signal transduction through CD28 and the related molecule CTLA4 prevented the induction of anergy in T cells activated through the TCR. This hypothesis has been suggested as an explanation for how soluble forms of CTLA4, which bind the CD28/CTLA4 ligands B7-1 and B7-2, can prevent graft rejection.
L H, Boise, P J, Noel, C B, Thompson
openaire +2 more sources
2018
CD28 was identified in early 1980s by Martin and colleagues by monoclonal antibodies recognizing a 44 kDa protein on the surface of human T lymphocytes (Martin et al. 1980). Further experiments from Gmunder and Lessener evidenced the crucial role of this molecule in costimulating T cell responses by synergizing with PHA in inducing T cell proliferation
openaire +2 more sources
CD28 was identified in early 1980s by Martin and colleagues by monoclonal antibodies recognizing a 44 kDa protein on the surface of human T lymphocytes (Martin et al. 1980). Further experiments from Gmunder and Lessener evidenced the crucial role of this molecule in costimulating T cell responses by synergizing with PHA in inducing T cell proliferation
openaire +2 more sources
Targeting CD4+CD28− T cells by blocking CD28 co-stimulation
Trends in Molecular Medicine, 2013In the August issue of Trends in Molecular Medicine, Broux et al. [1] discussed the potential mechanisms underlying the expansion of CD4+CD28− T lymphocytes (a population of effector memory cells with cytotoxic capacity and pathogenic potential) in patients with immune-related diseases, including rheumatoid arthritis (RA) [1].
Paolo, Airò, Mirko, Scarsi
openaire +2 more sources
The Journal of Immunology, 1993
Abstract Costimulatory molecules on the APC regulate T cell growth by providing signals that regulate responses to TCR occupancy. One such molecule is B7/BB-1, which triggers a T cell activation pathway by binding the CD28 and/or CTLA-4 cell-surface molecules.
P S, Linsley +4 more
openaire +2 more sources
Abstract Costimulatory molecules on the APC regulate T cell growth by providing signals that regulate responses to TCR occupancy. One such molecule is B7/BB-1, which triggers a T cell activation pathway by binding the CD28 and/or CTLA-4 cell-surface molecules.
P S, Linsley +4 more
openaire +2 more sources

